Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20250101 - 20251231
No. 1901 - 2000
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1901 | 24841623 |
FR |
80 | |
General physical health deterioration, COVID-19, |
||||
| 1902 | 24834176 |
IT |
||
General physical health deterioration, Epilepsy, Pulmonary infarction, Pulmonary embolism, |
||||
TRASTUZUMAB, TRASTUZUMAB, TUCATINIB, CAPECITABINE, PANTOPRAZOLE, BISOPROLOL FUMARATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1903 | 24834260 |
CA |
2 | |
Blister, Condition aggravated, Dyspnoea, Infection, Contusion, Duodenal ulcer perforation, Gastrointestinal disorder, Helicobacter infection, Ill-defined disorder, Abdominal discomfort, Contraindicated product administered, Folliculitis, Hand deformity, Rheumatoid arthritis, Systemic lupus erythematosus, Alopecia, Arthralgia, Glossodynia, Hypersensitivity, Infusion related reaction, Injury, Pericarditis, Arthropathy, Discomfort, Fatigue, Anti-cyclic citrullinated peptide antibody positive, Confusional state, General physical health deterioration, Hepatic enzyme increased, Impaired healing, |
||||
HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, HYDROCORTISONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREPITANT, FOSAPREPITANT DIMEGLUMINE, FOLIC ACID, SARILUMAB, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, SULFASALAZINE, DESOXIMETASONE, PREDNISONE, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, |
||||
| 1904 | 24834489 |
US |
70 | 2 |
Facial paralysis, Hand deformity, Arthropathy, Illness, Surgery, Hypoaesthesia, General physical health deterioration, Musculoskeletal disorder, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ETANERCEPT, ONABOTULINUMTOXINA, |
||||
| 1905 | 24834523 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1906 | 24834528 |
CA |
72 | 1 |
Acute myeloid leukaemia, Confusional state, Enterococcal sepsis, Febrile neutropenia, General physical health deterioration, Klebsiella sepsis, |
||||
AZACITIDINE, AZACITIDINE FOR, VENETOCLAX, MEROPENEM, VANCOMYCIN HYDROCHLORIDE, |
||||
| 1907 | 24834617 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1908 | 24834714 |
BR |
2 | |
Pyrexia, Arthralgia, Dizziness, Dementia, General physical health deterioration, Heart rate increased, Toothache, Product communication issue, |
||||
| 1909 | 24834735 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1910 | 24834745 |
FR |
55 | 1 |
Hyperleukocytosis, C-reactive protein increased, General physical health deterioration, |
||||
CARBOPLATIN, PEMETREXED DISODIUM, PEMBROLIZUMAB, |
||||
| 1911 | 24834835 |
CA |
40 | 2 |
Liver injury, Malaise, Drug-induced liver injury, Dizziness, Confusional state, Abdominal pain upper, Musculoskeletal stiffness, Grip strength decreased, Injection site reaction, Inflammation, Finger deformity, Glossodynia, Migraine, Pain, Pericarditis, Nasopharyngitis, Anti-cyclic citrullinated peptide antibody positive, Facet joint syndrome, Helicobacter infection, Hypoaesthesia, Insomnia, Musculoskeletal pain, Abdominal discomfort, Fall, Blister, Irritable bowel syndrome, Arthralgia, Memory impairment, Dyspnoea, Hypersensitivity, Folliculitis, Lung disorder, Fibromyalgia, Obesity, Lower respiratory tract infection, Mobility decreased, Breast cancer stage III, Night sweats, Fatigue, Gastrointestinal disorder, Onychomadesis, Paraesthesia, Nausea, Drug intolerance, Dry mouth, Drug ineffective, Dyspepsia, Epilepsy, Joint swelling, Adverse reaction, Pain in extremity, Arthropathy, Alopecia, Duodenal ulcer perforation, Condition aggravated, Infusion related reaction, Hypotension, Hepatic enzyme increased, Drug hypersensitivity, Ill-defined disorder, Depression, Diarrhoea, Hepatitis, Hand deformity, Joint range of motion decreased, Nail disorder, Neck pain, Coeliac disease, Lip dry, Muscle spasms, Off label use, Asthenia, Hypercholesterolaemia, Pemphigus, Osteoarthritis, Impaired healing, Contraindicated product administered, General physical health deterioration, Peripheral venous disease, Injury, Blepharospasm, Peripheral swelling, Blood cholesterol increased, Gait inability, Headache, Muscle injury, Bursitis, Back injury, Maternal exposure during pregnancy, Abdominal distension, Onychomycosis, Liver function test increased, C-reactive protein increased, C-reactive protein abnormal, |
||||
ACETAMINOPHEN AND CODEINE, MINOCYCLINE, MEPOLIZUMAB, INFLIXIMAB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, CANDESARTAN, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, HYDROXYCHLOROQUINE SULFATE, OXYCODONE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MIRABEGRON, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, SECUKINUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BOTULINUM TOXIN TYPE A, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, METHYLPREDNISOLONE, METHYLPREDNISOLONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LAMOTRIGINE, LAMOTRIGINE, NICOTINAMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, NAPROXEN, NAPROXEN SODIUM, SARILUMAB, VITAMIN C, TRAMADOL HYDROCHLORIDE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, INFLIXIMAB, ERENUMAB-AOOE, ATOMOXETINE, ATOMOXETINE, RANITIDINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, SULFASALAZINE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, USTEKINUMAB, USTEKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, BUPRENORPHINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, GOLD, GOLD, GOLD, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CELECOXIB, CELECOXIB, RAMIPRIL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, PREDNISONE, |
||||
| 1912 | 24835026 |
SE |
44 | 2 |
General physical health deterioration, Abdominal pain, Dizziness, Alanine aminotransferase increased, Headache, |
||||
METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 1913 | 24835297 |
IN |
76 | 2 |
Off label use, Flank pain, Decreased appetite, Asthenia, Diarrhoea, General physical health deterioration, |
||||
POLATUZUMAB VEDOTIN, POLATUZUMAB VEDOTIN, |
||||
| 1914 | 24835330 |
SE |
55 | 2 |
Pyrexia, Rash, Hepatic enzyme increased, General physical health deterioration, |
||||
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM, PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 1915 | 24835342 |
US |
1 | |
Prostate cancer, Malignant neoplasm progression, Cardiac failure, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1916 | 24835446 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1917 | 24835597 |
US |
6 | 2 |
Chest discomfort, Nausea, Dyspnoea, Vomiting, Therapy change, General physical health deterioration, Dermatitis contact, Hypotension, Oedema peripheral, |
||||
MACITENTAN, TREPROSTINIL, TREPROSTINIL, CLOPIDOGREL BISULFATE, LABETALOL HYDROCHLORIDE, LABETALOL, VITAMIN E, CREAM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, OXYGEN, 0XYGEN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, ALBUTEROL SULFATE, METOLAZONE, MIDODRINE HYDROCHLORIDE, IRON, |
||||
| 1918 | 24835764 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1919 | 24835783 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1920 | 24835948 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1921 | 24835959 |
CA |
16 | 2 |
Weight increased, Asthma, Borderline personality disorder, Decreased immune responsiveness, Dyspnoea, Dyspnoea exertional, Exercise tolerance decreased, Fatigue, General physical health deterioration, Oral discomfort, SARS-CoV-2 test positive, Sensitivity to weather change, Skin disorder, Suicidal ideation, Oral candidiasis, Drug hypersensitivity, Urticaria, Incorrect dose administered, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 1922 | 24836177 |
FR |
90 | 1 |
Loss of personal independence in daily activities, Interstitial lung disease, General physical health deterioration, Decreased appetite, Disorientation, Cognitive disorder, Fall, |
||||
EZETIMIBE, SILODOSIN, |
||||
| 1923 | 24836312 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1924 | 24836419 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1925 | 24836819 |
CH |
80 | 2 |
Neoplasm progression, Anaemia, General physical health deterioration, Fatigue, Anaemia, Anaemia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, DASATINIB, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, APIXABAN, |
||||
| 1926 | 24836846 |
IT |
72 | 1 |
General physical health deterioration, Cardiac disorder, |
||||
| 1927 | 24837097 |
DE |
1 | |
Colitis, Diarrhoea, Nausea, Vomiting, Diverticulum intestinal, General physical health deterioration, Gastritis, |
||||
CIPAGLUCOSIDASE ALFA-ATGA, MIGLUSTAT, |
||||
| 1928 | 24837364 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1929 | 24837581 |
FR |
55 | 1 |
General physical health deterioration, C-reactive protein increased, Hyperleukocytosis, |
||||
CARBOPLATIN, PEMETREXED DISODIUM, PEMBROLIZUMAB, |
||||
| 1930 | 24837671 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1931 | 24837761 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adverse drug reaction, Adverse event, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Condition aggravated, Confusional state, Depression, Diarrhoea, Discomfort, Dizziness, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fatigue, Fibromyalgia, Folliculitis, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver injury, Lower respiratory tract infection, Lung disorder, Maternal exposure during pregnancy, Memory impairment, Migraine, Muscle injury, Muscle spasms, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Night sweats, No adverse event, Obesity, Off label use, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Product quality issue, Product use in unapproved indication, Psoriatic arthropathy, Rash, Rheumatoid arthritis, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, CODEINE SULFATE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ALENDRONATE SODIUM, APREMILAST, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, MAGNESIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, MEPOLIZUMAB, ABATACEPT, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOPIRAMATE, TOPIRAMATE SPINKLE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, USTEKINUMAB, LORAZEPAM, CALCIUM, CYANOCOBALAMIN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, QUETIAPINE FUMARATE, QUETIAPINE, RISEDRONATE SODIUM, SULFASALAZINE, FISH OIL, |
||||
| 1932 | 24837793 |
CA |
80 | 1 |
Death, Abdominal distension, Abdominal pain, Anaemia, Analgesic therapy, Appendicitis, Appendicolith, Ascites, Bacterial infection, Blood cholesterol increased, Blood phosphorus increased, Blood uric acid increased, Cardiogenic shock, Chronic obstructive pulmonary disease, Condition aggravated, Constipation, Diabetes mellitus, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug therapy, Dry mouth, Dyspnoea, General physical health deterioration, Hyperphosphataemia, Hyponatraemia, Hypophosphataemia, Inappropriate schedule of product administration, Intentional product misuse, Iron deficiency, Multiple organ dysfunction syndrome, Myasthenia gravis, Nausea, Neuralgia, Off label use, Product use in unapproved indication, Pulmonary embolism, Sepsis, Sleep disorder therapy, Somnolence, Stress, Swelling, Thrombosis, Ventricular fibrillation, Vomiting, |
||||
DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, DARBEPOETIN ALFA, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALLANTOIN, MEDICINAL MASSAGE OIL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALUMINUM HYDROXIDE, BISMUTH, BISMUTH SUBSALICYLATE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, CEFTRIAXONE SODIUM, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, DEXTROSE MONOHYDRATE, DEXTROSE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, DOBUTAMINE HYDROCHLORIDE, FLUTICASONE PROPIONATE, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, INSULIN DEGLUDEC, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IRON, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, MAGNESIUM HYDROXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MAGNESIUM OXIDE, MANNITOL, MELATONIN, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE BITARTRATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, OSELTAMIVIR PHOSPHATE, OSELTAMIVIR ACID, OSELTAMIVIR, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SIMVASTATIN, SODIUM FERRIC GLUCONATE COMPLEX, THEOPHYLLINE, WARFARIN, WARFARIN, WARFARIN, WARFARIN, WARFARIN, |
||||
| 1933 | 24837806 |
SE |
90 | |
Depressed level of consciousness, General physical health deterioration, Urinary retention, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 1934 | 24837841 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1935 | 24837896 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1936 | 24837914 |
ES |
80 | |
Acute kidney injury, Urosepsis, General physical health deterioration, Hypotension, Enteritis, Diverticulum intestinal, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CARVEDILOL, CARVEDILOL, |
||||
| 1937 | 24837940 |
PL |
2 | |
Cytokine release syndrome, Venoocclusive liver disease, Oral disorder, Acute graft versus host disease, Weight increased, Drug hypersensitivity, General physical health deterioration, Vomiting, Capillary leak syndrome, Body temperature increased, Staphylococcal sepsis, Rash maculo-papular, Mouth ulceration, Nausea, Pancytopenia, Chronic graft versus host disease, Skin lesion, Diarrhoea, |
||||
CYCLOSPORINE, BASILIXIMAB, ETANERCEPT, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, |
||||
| 1938 | 24837967 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1939 | 24838056 |
FR |
41 | 1 |
Dyspnoea, General physical health deterioration, Nausea, Vomiting, Chills, Tremor, Hyperthermia, Neutropenia, |
||||
PIPERACILLIN SODIUM,TAZOBACTAM SODIUM, |
||||
| 1940 | 24838059 |
CA |
53 | 1 |
General physical health deterioration, Pain, |
||||
RITUXIMAB, FLURBIPROFEN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, |
||||
| 1941 | 24838064 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1942 | 24838071 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1943 | 24838120 |
CA |
77 | 1 |
Asthenia, Blood pressure increased, General physical health deterioration, Loss of personal independence in daily activities, Off label use, Wheelchair user, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, |
||||
| 1944 | 24838175 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1945 | 24838497 |
FR |
55 | 1 |
General physical health deterioration, C-reactive protein increased, Hyperleukocytosis, |
||||
CARBOPLATIN, PEMETREXED DISODIUM, PEMBROLIZUMAB, |
||||
| 1946 | 24838516 |
FR |
||
General physical health deterioration, Hypophagia, |
||||
VUTRISIRAN, VUTRISIRAN, |
||||
| 1947 | 24838547 |
US |
86 | 1 |
Visual impairment, General physical health deterioration, Asthenia, Pain, Balance disorder, Laboratory test abnormal, |
||||
TAFAMIDIS, TAFAMIDIS, |
||||
| 1948 | 24838669 |
US |
57 | 2 |
Hospitalisation, Large intestinal obstruction, Hypersensitivity, Illness, Vomiting, Colitis, Headache, Systemic lupus erythematosus, Swollen tongue, Cough, Colon cancer, Diarrhoea, Visual impairment, Arthralgia, Pain, Abdominal pain, Immunodeficiency, Asthma, Deep vein thrombosis, Dysuria, Joint swelling, General physical health deterioration, Eye inflammation, Fatigue, Eye disorder, Disability, Vascular occlusion, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, SEMAGLUTIDE, BUSPIRONE HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, FOLIC ACID, ERGOCALCIFEROL, METHOTREXATE SODIUM, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, LORATADINE, |
||||
| 1949 | 24833616 |
DE |
2 | |
Sleep disorder, Sudden onset of sleep, Somnolence, Disturbance in attention, General physical health deterioration, Gamma-glutamyltransferase increased, |
||||
AMLODIPINE, BISOPROLOL FUMARATE, APIXABAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SIMVASTATIN, PREGABALIN, PREGABALIN, TORSEMIDE, |
||||
| 1950 | 24833673 |
IL |
81 | 1 |
General physical health deterioration, Hypophagia, Pneumonia, |
||||
| 1951 | 24833674 |
FR |
76 | 1 |
SARS-CoV-2 test positive, General physical health deterioration, Asthenia, |
||||
| 1952 | 24833698 |
IT |
77 | 1 |
General physical health deterioration, |
||||
CARBIDOPA AND LEVODOPA, CARBIDOPA AND LEVODOPA, |
||||
| 1953 | 24833727 |
CO |
73 | 1 |
Gastric cancer, General physical health deterioration, |
||||
ADALIMUMAB, |
||||
| 1954 | 24828551 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1955 | 24828949 |
US |
1 | |
Respiratory failure, Immobilisation prolonged, Pulmonary oedema, General physical health deterioration, Sleep deficit, Dyspnoea, Aspiration pleural cavity, Fluid intake reduced, Feeding disorder, |
||||
BRIVARACETAM, MORPHINE, |
||||
| 1956 | 24829071 |
IT |
63 | 1 |
Syncope, Electrocardiogram ST-T segment abnormal, Treatment noncompliance, Off label use, General physical health deterioration, Diarrhoea, Drug intolerance, |
||||
OXALIPLATIN, OXALIPLATIN, LEVOLEUCOVORIN, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, LEVOLEUCOVORIN CALCIUM, TUCATINIB, TUCATINIB, FLUOROURACIL, FLUOROURACIL, LEUCOVORIN CALCIUM, TRASTUZUMAB, PANTOPRAZOLE, ENOXAPARIN SODIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 1957 | 24829092 |
US |
74 | 2 |
Incorrect dose administered, Fall, Intervertebral disc protrusion, Pain, General physical health deterioration, Drug ineffective, Injection site bruising, Injection site pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1958 | 24829284 |
US |
2 | |
Hallucination, Feeling abnormal, General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1959 | 24829302 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1960 | 24829687 |
CA |
59 | 2 |
Hepatic cirrhosis, Red blood cell sedimentation rate increased, Ear infection, Pneumonia, Drug hypersensitivity, Rash, Wound, Foot deformity, Infusion related reaction, Retinitis, Drug intolerance, Hypersensitivity, Dizziness, Headache, Discomfort, Laryngitis, Glossodynia, Alopecia, General physical health deterioration, Osteoporosis, Hepatic enzyme increased, Pericarditis, Visual impairment, Infection, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, AZATHIOPRINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, CYCLOSPORINE, SECUKINUMAB, SECUKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE, QUETIAPINE FUMARATE, QUETIAPINE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, RAMIPRIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, SULFASALAZINE, AMLODIPINE, BUPROPION HYDROCHLORIDE, CAFFEINE CITRATE, BUPROPION HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ERGOCALCIFEROL, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LISINOPRIL, CALCIUM GLUCONATE, HYDROMORPHONE HYDROCHLORIDE, ACETAMINOPHEN AND CODEINE, LORAZEPAM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, SECUKINUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC, DICLOFENAC SODIUM, HYDROMORPHONE HYDROCHLORIDE, |
||||
| 1961 | 24829713 |
DE |
||
Autoimmune hepatitis, General physical health deterioration, |
||||
BEVACIZUMAB, PEMBROLIZUMAB, |
||||
| 1962 | 24829743 |
CA |
40 | 2 |
Pemphigus, Hypertension, Lip dry, Hypoaesthesia, Pain, Drug hypersensitivity, Condition aggravated, Osteoarthritis, Arthralgia, Peripheral swelling, Inflammation, Injury, Blepharospasm, Grip strength decreased, Asthenia, Fibromyalgia, Depression, Insomnia, Drug intolerance, Liver injury, Back injury, Live birth, Dry mouth, Finger deformity, Blister, Nasopharyngitis, Night sweats, Onychomadesis, Bursitis, Injection site reaction, Joint range of motion decreased, Hypersensitivity, Anti-cyclic citrullinated peptide antibody positive, Overdose, Liver function test increased, Blood cholesterol increased, Dyspepsia, Glossodynia, Onychomycosis, Arthropathy, Fatigue, Impaired healing, Dyspnoea, Folliculitis, Facet joint syndrome, Infusion related reaction, Diarrhoea, Abdominal distension, Dizziness, Gait inability, Musculoskeletal pain, Nail disorder, Abdominal discomfort, Irritable bowel syndrome, Lung disorder, C-reactive protein increased, Obesity, Helicobacter infection, Musculoskeletal stiffness, Pain in extremity, General physical health deterioration, Paraesthesia, Hand deformity, Underdose, Mobility decreased, Hepatitis, Exposure during pregnancy, Drug-induced liver injury, Drug ineffective, Ill-defined disorder, C-reactive protein abnormal, Fall, Off label use, Confusional state, Pneumonia, Adverse reaction, Lower respiratory tract infection, Coeliac disease, Pericarditis, Maternal exposure during pregnancy, Malaise, Contraindicated product administered, Headache, Neck pain, Migraine, Joint swelling, Epilepsy, Breast cancer stage III, Duodenal ulcer perforation, Nausea, Muscle spasms, Muscle injury, Hypercholesterolaemia, Abdominal pain upper, Intentional product use issue, Gastrointestinal disorder, Alopecia, Hepatic enzyme increased, Peripheral venous disease, Memory impairment, |
||||
ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE, ACETAMINOPHEN AND CODEINE, INFLIXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, BOTULINUM TOXIN TYPE A, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, GOLD, GOLD, GOLD, GOLD, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SECUKINUMAB, SECUKINUMAB, VITAMIN C, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, RAMIPRIL, RAMIPRIL, RAMIPRIL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ATOMOXETINE, ATOMOXETINE, ATOMOXETINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, TRAMADOL HYDROCHLORIDE, OXYCODONE, OXYCODONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, NICOTINAMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METHYLPREDNISOLONE, METHYLPREDNISOLONE, SULFASALAZINE, CANDESARTAN, LEFLUNOMIDE, LEFLUNOMIDE, MIRABEGRON, MIRABEGRON, MEPOLIZUMAB, BUPRENORPHINE, BUPRENORPHINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, RANITIDINE, PREDNISONE, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
| 1963 | 24829998 |
CA |
65 | 1 |
Asthenia, Dysstasia, General physical health deterioration, Balance disorder, Gait disturbance, Grunting, Micturition urgency, Hypotension, Cardiac disorder, Defaecation urgency, Ill-defined disorder, Pulmonary oedema, Cardiac failure congestive, Cough, Pain, Fatigue, Rash pruritic, Injection site pain, Hypersensitivity, Diarrhoea, Malaise, Pruritus, Vomiting, Urticaria, Drug ineffective, Wrong technique in product usage process, |
||||
ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, ADALIMUMAB-AFZB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, HYDROXYCHLOROQUINE, LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE, LOSARTAN, METHYLPREDNISOLONE, ROSUVASTATIN CALCIUM, |
||||
| 1964 | 24830221 |
US |
73 | 2 |
Death, Pneumonia aspiration, Right ventricular failure, Confusional state, General physical health deterioration, |
||||
RIOCIGUAT, APIXABAN, DIGOXIN, BISOPROLOL FUMARATE, FLUTICASONE PROPIONATE AND SALMETEROL, ALBUTEROL SULFATE, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREDNISONE, ASCORBIC ACID, |
||||
| 1965 | 24830429 |
CA |
44 | 2 |
Abdominal discomfort, Pemphigus, General physical health deterioration, Headache, Pericarditis, Hypertension, Inflammation, Helicobacter infection, Hypoaesthesia, Hand deformity, Injury, Hepatic enzyme increased, Ill-defined disorder, Hypersensitivity, Liver injury, Insomnia, Infusion related reaction, Blister, Pain, Impaired healing, Drug ineffective, Intentional product use issue, Decreased appetite, Gastrointestinal disorder, Alopecia, Glossodynia, Nasopharyngitis, Sciatica, Irritable bowel syndrome, Anti-cyclic citrullinated peptide antibody positive, Discomfort, Drug hypersensitivity, Infection, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, CELECOXIB, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ACETAMINOPHEN AND CODEINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CAFFEINE, LORAZEPAM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, FOLIC ACID, FOLIC ACID, TOCILIZUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, PREDNISONE, PREDNISONE, PREDNISONE, ERGOCALCIFEROL, ACETAMINOPHEN AND CODEINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, TRIMETHOPRIM, PREDNISONE, HYDROCORTISONE BUTYRATE, ERGOCALCIFEROL, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, USTEKINUMAB, GOLIMUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, CORTISONE ACETATE, CORTISONE ACETATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LORAZEPAM, LANSOPRAZOLE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, ADALIMUMAB, DICLOFENAC, DICLOFENAC SODIUM, VITAMIN C, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ALENDRONATE SODIUM, SECUKINUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, HYDROXYCHLOROQUINE SULFATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 1966 | 24830529 |
FR |
90 | 1 |
Interstitial lung disease, Loss of personal independence in daily activities, General physical health deterioration, Decreased appetite, Disorientation, Fall, Cognitive disorder, |
||||
SILODOSIN, EZETIMIBE, |
||||
| 1967 | 24830897 |
CA |
43 | 2 |
Depression, Migraine, Off label use, Irritable bowel syndrome, Product quality issue, Wound infection, Back injury, Inflammation, Systemic lupus erythematosus, Therapeutic product effect decreased, Glossodynia, Muscle spasms, Vomiting, Pain, Arthropathy, Nail disorder, Blood cholesterol increased, Infusion related reaction, Confusional state, Rheumatoid arthritis, Urticaria, Intentional product use issue, Therapeutic product effect incomplete, Injury, Impaired healing, Lung disorder, Abdominal discomfort, Nasopharyngitis, Nausea, Weight increased, Muscle injury, Hepatic enzyme increased, Pain in extremity, Obesity, Peripheral swelling, Drug intolerance, Dizziness, Swelling, Pneumonia, Pericarditis, Blister, Asthenia, Liver injury, Taste disorder, Bursitis, Joint range of motion decreased, Anti-cyclic citrullinated peptide antibody positive, Facet joint syndrome, Live birth, Lip dry, Gastrooesophageal reflux disease, Dry mouth, Folliculitis, Osteoarthritis, Drug hypersensitivity, Contraindicated product administered, Joint swelling, Infusion site reaction, Hypertension, Breast cancer stage III, General physical health deterioration, C-reactive protein increased, Musculoskeletal pain, Gait inability, Rheumatic fever, Blepharospasm, Stomatitis, Liver function test increased, Alopecia, Sleep disorder, Duodenal ulcer perforation, Hypercholesterolaemia, Muscular weakness, Synovitis, Abdominal pain upper, Helicobacter infection, Diarrhoea, Drug ineffective, Psoriatic arthropathy, Peripheral venous disease, Night sweats, Arthralgia, Lower respiratory tract infection, Onychomadesis, Epilepsy, Paraesthesia, Maternal exposure during pregnancy, Product use in unapproved indication, Pemphigus, Rash, Mobility decreased, Wound, Hand deformity, Type 2 diabetes mellitus, Product use issue, Neck pain, Hypoaesthesia, Memory impairment, Treatment failure, Fibromyalgia, Oedema, Decreased appetite, Disability, Insomnia, Breast cancer stage II, Dislocation of vertebra, Delirium, Condition aggravated, Respiratory disorder, Amnesia, Sciatica, Gait disturbance, Autoimmune disorder, Asthma, C-reactive protein, Chest pain, Contusion, Deep vein thrombosis postoperative, Ill-defined disorder, Knee arthroplasty, Exposure during pregnancy, Liver disorder, Discomfort, Infection, Headache, Rheumatoid factor positive, Pruritus, Anxiety, Lower limb fracture, Malaise, Fatigue, Gastrointestinal disorder, Hypersensitivity, Dyspnoea, Adjustment disorder with depressed mood, Ear pain, Grip strength decreased, Normal newborn, Swollen joint count increased, Pregnancy, Pyrexia, Wheezing, Road traffic accident, Walking aid user, Weight decreased, X-ray abnormal, Prescribed overdose, Sinusitis, Therapy non-responder, C-reactive protein abnormal, Musculoskeletal stiffness, |
||||
FLUTICASONE PROPIONATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, MINOCYCLINE, MEPOLIZUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, VITAMIN C, TRETINOIN, BOTULINUM TOXIN TYPE A, AZELAIC ACID, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, RAMIPRIL, RAMIPRIL, METHYLPREDNISOLONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, PHOSPHORUS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ERGOCALCIFEROL, CORTISONE ACETATE, BUPRENORPHINE, ALENDRONATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TRAMADOL HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, MIRABEGRON, MIRABEGRON, MIRABEGRON, ABATACEPT, ATOMOXETINE, ATOMOXETINE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, AZATHIOPRINE, RANITIDINE, USTEKINUMAB, CELECOXIB, CELECOXIB, MAGNESIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, GOLIMUMAB, CYCLOBENZAPRINE, APREMILAST, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, LEVOMILNACIPRAN, SARILUMAB, INFLIXIMAB, TOFACITINIB, PANTOPRAZOLE, ERENUMAB-AOOE, ERENUMAB-AOOE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CANDESARTAN, CANDESARTAN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, RITUXIMAB-ARRX, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, |
||||
| 1968 | 24831274 |
CA |
2 | |
Abdominal discomfort, Exposure during pregnancy, Hand deformity, Arthropathy, Product use issue, Malaise, Musculoskeletal stiffness, Synovitis, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Discomfort, Joint swelling, Adverse drug reaction, Diarrhoea, Pain, Type 2 diabetes mellitus, Maternal exposure during pregnancy, Treatment failure, Drug intolerance, Injury, Fatigue, Pericarditis, Rash, Fibromyalgia, Rheumatic fever, Drug ineffective, Anti-cyclic citrullinated peptide antibody positive, Swelling, Infusion related reaction, Therapeutic product effect decreased, Psoriatic arthropathy, Contraindicated product administered, Rheumatoid arthritis, Blood cholesterol increased, Hypertension, Hypoaesthesia, Adverse event, Duodenal ulcer perforation, Systemic lupus erythematosus, Blister, Decreased appetite, Alopecia, Glossodynia, Rheumatoid factor positive, Wound, Mobility decreased, Headache, Liver injury, Hypersensitivity, Arthralgia, Intentional product use issue, Pemphigus, General physical health deterioration, |
||||
METHOTREXATE, METHOTREXATE SODIUM, LISINOPRIL, CERTOLIZUMAB PEGOL, TOCILIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, GOLIMUMAB, TOFACITINIB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, CAFFEINE CITRATE, ETANERCEPT, CALCIUM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, PREDNISONE, CORTISONE ACETATE, SULFASALAZINE, PREDNISONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROCORTISONE ACETATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, USTEKINUMAB, USTEKINUMAB, TOCILIZUMAB, DESOXIMETASONE, DESOXIMETASONE, CERTOLIZUMAB PEGOL, PREDNISONE, ERGOCALCIFEROL, APREMILAST, RITUXIMAB, RITUXIMAB, INFLIXIMAB, SECUKINUMAB, SECUKINUMAB, GOLIMUMAB, LEFLUNOMIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, FOLIC ACID, LEFLUNOMIDE, ABATACEPT, |
||||
| 1969 | 24831284 |
CA |
45 | 2 |
Infusion related reaction, Muscular weakness, Pain in extremity, Fatigue, Ear infection, Arthralgia, Joint swelling, Peripheral swelling, Erythema, Asthenia, Sinusitis, Limb discomfort, Pain in extremity, Pollakiuria, Fatigue, Urinary tract infection, Pyrexia, Agitation, General physical health deterioration, Sepsis, Memory impairment, Gastrooesophageal reflux disease, |
||||
OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, OCRELIZUMAB, |
||||
| 1970 | 24831354 |
DE |
2 | |
Sudden onset of sleep, Gamma-glutamyltransferase increased, Disturbance in attention, Sleep disorder, General physical health deterioration, Somnolence, |
||||
AMLODIPINE, APIXABAN, PREGABALIN, PREGABALIN, TORSEMIDE, SIMVASTATIN, BISOPROLOL FUMARATE, PANTOPRAZOLE, |
||||
| 1971 | 24831726 |
JP |
2 | |
General physical health deterioration, |
||||
ARIPIPRAZOLE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 1972 | 24832441 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1973 | 24832462 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Adverse reaction, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypoaesthesia, Hypotension, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Maternal exposure during pregnancy, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Off label use, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, |
||||
BUPRENORPHINE, OXYCODONE HYDROCHLORIDE, OXYCODONE, TRAMADOL HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC, DICLOFENAC SODIUM, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE, MINOCYCLINE, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, VITAMIN C, |
||||
| 1974 | 24832813 |
SE |
80 | 2 |
Death, General physical health deterioration, |
||||
| 1975 | 24832815 |
US |
43 | 2 |
Psychotic disorder, Hallucination, auditory, Delusion, General physical health deterioration, Post-traumatic stress disorder, Intentional product misuse, |
||||
THYROID, PORCINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM, |
||||
| 1976 | 24822521 |
TR |
74 | 1 |
General physical health deterioration, Confusional state, Loss of consciousness, |
||||
| 1977 | 24822555 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1978 | 24822631 |
US |
||
Abdominal pain, Laboratory test abnormal, General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1979 | 24822647 |
US |
||
Malaise, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1980 | 24822659 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1981 | 24822692 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1982 | 24822693 |
US |
1 | |
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1983 | 24822774 |
US |
1 | |
Disease progression, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1984 | 24822790 |
US |
||
Product substitution issue, Therapeutic response decreased, General physical health deterioration, |
||||
CLOZAPINE, CLOZAPINE, |
||||
| 1985 | 24822996 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1986 | 24823038 |
BE |
||
Death, General physical health deterioration, |
||||
DURVALUMAB, CARBOPLATIN, ETOPOSIDE, |
||||
| 1987 | 24823172 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 1988 | 24823361 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1989 | 24823386 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1990 | 24823399 |
US |
1 | |
General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1991 | 24823429 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1992 | 24823729 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 1993 | 24823838 |
PL |
||
General physical health deterioration, Pallor, Hyperhidrosis, Chills, Blood pressure increased, Tachycardia, |
||||
TRASTUZUMAB, |
||||
| 1994 | 24824036 |
US |
60 | 1 |
Pain, Malaise, General physical health deterioration, Gait inability, |
||||
ABATACEPT, |
||||
| 1995 | 24824066 |
US |
||
General physical health deterioration, Brain fog, Depression, Pain, Weight increased, Suicidal ideation, Blood glucose increased, Joint swelling, Asthenia, Dysstasia, Fall, |
||||
ASFOTASE ALFA, GABAPENTIN, |
||||
| 1996 | 24824074 |
US |
39 | 2 |
Pain, General physical health deterioration, Therapeutic product effect decreased, |
||||
OZANIMOD HYDROCHLORIDE, OZANIMOD HYDROCHLORIDE, |
||||
| 1997 | 24824312 |
RO |
76 | 1 |
Death, Pulmonary mass, Hilar lymphadenopathy, Lymphadenopathy mediastinal, Aortic arteriosclerosis, Liver injury, Diarrhoea, Weight decreased, Asthenia, Hepatic cytolysis, Pain, Muscle contractions involuntary, Thrombocytopenia, Pyrexia, Chills, Cholestasis, Biliary dilatation, Leukocytosis, Neutrophilia, Inflammation, General physical health deterioration, Off label use, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 1998 | 24824358 |
DE |
1 | |
Parkinson^s disease, General physical health deterioration, Pneumonia, Unresponsive to stimuli, Feeling abnormal, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1999 | 24824450 |
CA |
76 | 2 |
Rheumatoid arthritis, General physical health deterioration, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, |
||||
| 2000 | 24824710 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28